The Exon 8-Containing Prosaposin Gene Splice Variant Is Dispensable for Mouse Development, Lysosomal Function, and Secretion

REFERENCES

• Ahn, V. E., K. F. Faull, J. P. Whitelegge, A. L. Fluharty, and G. G. Prive. 2003. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad. Sci. USA 100:38–43.
   PubMedGoogle Scholar
• Amann, R. P., R. H. Hammerstedt, and R. B. Shabanowitz. 1999. Exposure of human, boar, or bull sperm to a synthetic peptide increases binding to an egg-membrane substrate. J. Androl. 20:34–41.
   PubMedGoogle Scholar
• Arundine, M., and M. Tymianski. 2004. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61:657–668.
   PubMed Web of Science ®Google Scholar
• Bodennec, J., O. Koul, I. Aguado, G. Brichon, G. Zwingelstein, and J. Portoukalian. 2000. A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J. Lipid Res. 41:1524–1531.
   PubMedGoogle Scholar
• Bodennec, J., S. Trajkovic-Bodennec, and A. H. Futerman. 2003. Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride. J. Lipid Res. 44:1413–1419.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cohen, T., L. Ravid, N. Altman, L. Madar-Shapiro, A. Fein, M. Weil, and M. Horowitz. 2004. Conservation of expression and alternative splicing in the prosaposin gene. Brain Res. Mol. Brain Res. 129:8–19.
   PubMedGoogle Scholar
• Fischer, G., and H. Jatzkewitz. 1977. The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein. Biochim. Biophys. Acta 481:561–572.
   PubMedGoogle Scholar
• Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497–509.
   PubMed Web of Science ®Google Scholar
• Fu, Q., G. S. Carson, M. Hiraiwa, M. Grafe, Y. Kishimoto, and J. S. O'Brien. 1994. Occurrence of prosaposin as a neuronal surface membrane component. J. Mol. Neurosci. 5:59–67.
   PubMedGoogle Scholar
• Fujita, N., K. Suzuki, M. T. Vanier, B. Popko, N. Maeda, A. Klein, M. Henseler, K. Sandhoff, H. Nakayasu, and K. Suzuki. 1996. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet. 5:711–725.
   PubMedGoogle Scholar
• Ham, D. 2003. Structural requirements for lysosomal targeting of the prosaposin precursor protein. Cell Biol. Int. 27:675–687.
   PubMedGoogle Scholar
• Hammerstedt, R. H., P. G. Cramer, G. F. Barbato, R. P. Amann, J. S. O'Brien, and M. D. Griswold. 2001. A fragment of prosaposin (SGP-1) from rooster sperm promotes sperm-egg binding and improves fertility in chickens. J. Androl. 22:361–375.
   PubMedGoogle Scholar
• Hanks, M., W. Wurst, L. Anson-Cartwright, A. B. Auerbach, and A. L. Joyner. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679–682.
   PubMedGoogle Scholar
• Harzer, K., B. C. Paton, A. Poulos, B. Kustermann-Kuhn, W. Roggendorf, T. Grisar, and M. Popp. 1989. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur. J. Pediatr. 149:31–39.
   PubMed Web of Science ®Google Scholar
• Henseler, M., A. Klein, G. J. Glombitza, K. Suziki, and K. Sandhoff. 1996. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system. J. Biol. Chem. 271:8416–8423.
   PubMedGoogle Scholar
• Hineno, T., A. Sano, K. Kondoh, S. Ueno, Y. Kakimoto, and K. Yoshida. 1991. Secretion of sphingolipid hydrolase activator precursor, prosaposin. Biochem. Biophys. Res. Commun. 176:668–674.
   PubMedGoogle Scholar
• Hiraiwa, M., W. M. Campana, A. P. Mizisin, L. Mohiuddin, and J. S. O'Brien. 1999. Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury. Glia 26:353–360.
   PubMedGoogle Scholar
• Hiraiwa, M., J. Liu, A. G. Lu, C. Y. Wang, R. Misasi, T. Yamauchi, I. Hozumi, T. Inuzuka, and J. S. O'Brien. 2003. Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain. J. Neurotrauma 20:755–765.
   PubMedGoogle Scholar
• Hiraiwa, M., J. S. O'Brien, Y. Kishimoto, M. Galdzicka, A. L. Fluharty, E. I. Ginns, and B. M. Martin. 1993. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch. Biochem. Biophys. 304:110–116.
   PubMedGoogle Scholar
• Hiraiwa, M., S. Soeda, Y. Kishimoto, and J. S. O'Brien. 1992. Binding and transport of gangliosides by prosaposin. Proc. Natl. Acad. Sci. USA 89:11254–11258.
   PubMed Web of Science ®Google Scholar
• Hiraiwa, M., E. M. Taylor, W. M. Campana, S. J. Darin, and J. S. O'Brien. 1997. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl. Acad. Sci. USA 94:4778–4781.
   PubMedGoogle Scholar
• Holtschmidt, H., K. Sandhoff, H. Y. Kwon, K. Harzer, T. Nakano, and K. Suzuki. 1991. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J. Biol. Chem. 266:7556–7560.
   PubMedGoogle Scholar
• Hozumi, I., M. Hiraiwa, T. Inuzuka, Y. Yoneoka, K. Akiyama, R. Tanaka, K. Kikugawa, R. Nakano, S. Tsuji, and J. S. O'Brien. 1999. Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain. Neurosci. Lett. 267:73–76.
   PubMedGoogle Scholar
• Huettner, J. E. 2003. Kainate receptors and synaptic transmission. Prog. Neurobiol. 70:387–407.
   PubMed Web of Science ®Google Scholar
• Hulkova, H., M. Cervenkova, J. Ledvinova, M. Tochackova, M. Hrebicek, H. Poupetova, A. Befekadu, L. Berna, B. C. Paton, K. Harzer, A. Boor, F. Smid, and M. Elleder. 2001. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum. Mol. Genet. 10:927–940.
   PubMedGoogle Scholar
• Kishimoto, Y., M. Hiraiwa, and J. S. O'Brien. 1992. Saposins: structure, function, distribution, and molecular genetics. J. Lipid Res. 33:1255–1267.
   PubMedGoogle Scholar
• Klein, A., M. Henseler, C. Klein, K. Suzuki, K. Harzer, and K. Sandhoff. 1994. Sphingolipid activator protein D (Sap-D) stimulates the lysosomal degradation of ceramide in-vivo. Biochem. Biophys. Res. Commun. 200:1440–1448.
   PubMedGoogle Scholar
• Kondoh, K., T. Hineno, A. Sano, and Y. Kakimoto. 1991. Isolation and characterization of prosaposin from human milk. Biochem. Biophys. Res. Commun. 181:286–292.
   PubMed Web of Science ®Google Scholar
• Kotani, Y., S. Matsuda, M. Sakanaka, K. Kondoh, S. Ueno, and A. Sano. 1996. Prosaposin facilitates sciatic nerve regeneration in vivo. J. Neurochem. 66:2019–2025.
   PubMedGoogle Scholar
• Kretz, K. A., G. S. Carson, S. Morimoto, Y. Kishimoto, A. L. Fluharty, and J. S. O'Brien. 1990. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Proc. Natl. Acad. Sci. USA 87:2541–2544.
   PubMed Web of Science ®Google Scholar
• Lamontagne, S., and M. Potier. 1994. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides. J. Biol. Chem. 269:20528–20532.
   PubMedGoogle Scholar
• Leonova, T., X. Qi, A. Bencosme, E. Ponce, Y. Sun, and G. A. Grabowski. 1996. Proteolytic processing patterns of prosaposin in insect and mammalian cells. J. Biol. Chem. 271:17312–17320.
   PubMed Web of Science ®Google Scholar
• Li Song, D., and A. L. Joyner. 2000. Two Pax2/5/8-binding sites in Engrailed2 are required for proper initiation of endogenous mid-hindbrain expression. Mech. Dev. 90:155–165.
   PubMedGoogle Scholar
• Madar-Shapiro, L., M. Pasmanik-Chor, A. M. Vaccaro, T. Dinur, A. Dagan, S. Gatt, and M. Horowitz. 1999. Importance of splicing for prosaposin sorting. Biochem. J. 337:433–443.
   PubMedGoogle Scholar
• Matsuda, J., M. Kido, K. Tadano-Aritomi, I. Ishizuka, K. Tominaga, K. Toida, E. Takeda, K. Suzuki, and Y. Kuroda. 2004. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in the mouse. Hum. Mol. Genet. 13:2709–2723.
   PubMedGoogle Scholar
• Matsuda, J., M. T. Vanier, Y. Saito, J. Tohyama, and K. Suzuki. 2001. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Hum. Mol. Genet. 10:1191–1199.
   PubMedGoogle Scholar
• McKinnell, C., and R. M. Sharpe. 1997. Regulation of the secretion and synthesis of rat Sertoli cell SGP-1, SGP-2 and CP-2 by elongate spermatids. Int. J. Androl. 20:171–179.
   PubMedGoogle Scholar
• Misasi, R., M. Sorice, T. Garofalo, T. Griggi, W. M. Campana, M. Giammatteo, A. Pavan, M. Hiraiwa, G. M. Pontieri, and J. S. O'Brien. 1998. Colocalization and complex formation between prosaposin and monosialoganglioside GM3 in neural cells. J. Neurochem. 71:2313–2321.
   PubMedGoogle Scholar
• Morales, C. R., and H. Badran. 2003. Prosaposin ablation inactivates the MAPK and Akt signaling pathways and interferes with the development of the prostate gland. Asian J. Androl. 5:57–63.
   PubMedGoogle Scholar
• Morales, C. R., N. Hay, M. El-Alfy, and Q. Zhao. 1998. Distribution of mouse sulfated glycoprotein-1 (prosaposin) in the testis and other tissues. J. Androl. 19:156–164.
   PubMedGoogle Scholar
• Morales, C. R., Q. Zhao, M. El-Alfy, and K. Suzuki. 2000. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. J. Androl. 21:765–775.
   PubMedGoogle Scholar
• Morita, F., T. C. Wen, J. Tanaka, R. Hata, J. Desaki, K. Sato, K. Nakata, Y. J. Ma, and M. Sakanaka. 2001. Protective effect of a prosaposin-derived, 18-mer peptide on slowly progressive neuronal degeneration after brief ischemia. J. Cereb. Blood Flow Metab. 21:1295–1302.
   PubMedGoogle Scholar
• Nakano, T., K. Sandhoff, J. Stumper, H. Christomanou, and K. Suzuki. 1989. Structure of full-length cDNA coding for sulfatide activator, a co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator. J. Biochem. (Tokyo) 105:152–154.
   PubMedGoogle Scholar
• O'Brien, J. S., G. S. Carson, H. C. Seo, M. Hiraiwa, and Y. Kishimoto. 1994. Identification of prosaposin as a neurotrophic factor. Proc. Natl. Acad. Sci. USA 91:9593–9596.
   PubMed Web of Science ®Google Scholar
• Plowman, S. J., D. J. Williamson, M. J. O'Sullivan, J. Doig, A. M. Ritchie, D. J. Harrison, D. W. Melton, M. J. Arends, M. L. Hooper, and C. E. Patek. 2003. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol. Cell. Biol. 23:9245–9250.
   PubMedGoogle Scholar
• Rafi, M. A., G. de Gala, X. L. Zhang, and D. A. Wenger. 1993. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat. Cell Mol. Genet. 19:1–7.
   PubMedGoogle Scholar
• Rafi, M. A., X. L. Zhang, G. DeGala, and D. A. Wenger. 1990. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy. Biochem. Biophys. Res. Commun. 166:1017–1023.
   PubMedGoogle Scholar
• Regis, S., M. Filocamo, F. Corsolini, F. Caroli, J. L. Keulemans, O. P. van Diggelen, and R. Gatti. 1999. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity. Eur. J. Hum. Genet. 7:125–130.
   PubMedGoogle Scholar
• Rende, M., E. Brizi, R. Donato, C. Provenzano, R. Bruno, A. P. Mizisin, R. S. Garrett, N. A. Calcutt, W. M. Campana, and J. S. O'Brien. 2001. Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury. Muscle Nerve 24:799–808.
   PubMedGoogle Scholar
• Sandhoff, K., K. Harzer, and W. Furst. 1995. Sphingolipid activator proteins, p. 2427–2441. In S. Scriber, A. Beaudet, W. Sly, and D. Valle (ed.), The metabolic and molecular basis of inherited disease, 7th ed. McGraw-Hill, New York, N.Y.
   Google Scholar
• Sandhoff, K., and T. Kolter. 2003. Biosynthesis and degradation of mammalian glycosphingolipids. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358:847–861.
   PubMedGoogle Scholar
• Sano, A., T. Hineno, T. Mizuno, K. Kondoh, S. Ueno, Y. Kakimoto, and K. Inui. 1989. Sphingolipid hydrolase activator proteins and their precursors. Biochem. Biophys. Res. Commun. 165:1191–1197.
   PubMedGoogle Scholar
• Sano, A., S. Matsuda, T. C. Wen, Y. Kotani, K. Kondoh, S. Ueno, Y. Kakimoto, H. Yoshimura, and M. Sakanaka. 1994. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem. Biophys. Res. Commun. 204:994–1000.
   PubMed Web of Science ®Google Scholar
• Schlote, W., K. Harzer, H. Christomanou, B. C. Paton, B. Kustermann-Kuhn, B. Schmid, J. Seeger, U. Beudt, I. Schuster, and U. Langenbeck. 1991. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur. J. Pediatr. 150:584–591.
   PubMedGoogle Scholar
• Schnabel, D., M. Schroder, W. Furst, A. Klein, R. Hurwitz, T. Zenk, J. Weber, K. Harzer, B. C. Paton, A. Poulos, K. Suzuki, and K. Sandhoff. 1992. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J. Biol. Chem. 267:3312–3315.
   PubMed Web of Science ®Google Scholar
• Schnabel, D., M. Schroder, and K. Sandhoff. 1991. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 284:57–59.
   PubMed Web of Science ®Google Scholar
• Sprecher-Levy, H., A. Orr-Urtreger, P. Lonai, and M. Horowitz. 1993. Murine prosaposin: expression in the reproductive system of a gene implicated in human genetic diseases. Cell. Mol. Biol. (Noisy-Le-Grand) 39:287–299.
   PubMedGoogle Scholar
• Sylvester, S. R., C. Morales, R. Oko, and M. D. Griswold. 1989. Sulfated glycoprotein-1 (saposin precursor) in the reproductive tract of the male rat. Biol. Reprod. 41:941–948.
   PubMed Web of Science ®Google Scholar
• Tsuboi, K., M. Hiraiwa, and J. S. O'Brien. 1998. Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture. Brain Res. Dev. Brain Res. 110:249–255.
   PubMedGoogle Scholar
• Wells, M. A., and J. C. Dittmer. 1963. The use of Sephadex for the removal of nonlipid contaminants from lipid extracts. Biochemistry 172:1259–1263.
   Google Scholar
• White, J. K., W. Auerbach, M. P. Duyao, J. P. Vonsattel, J. F. Gusella, A. L. Joyner, and M. E. MacDonald. 1997. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17:404–410.
   PubMed Web of Science ®Google Scholar
• Wrobe, D., M. Henseler, S. Huettler, S. I. Pascual Pascual, A. Chabas, and K. Sandhoff. 2000. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). J. Inherit. Metab. Dis. 23:63–76.
   PubMedGoogle Scholar
• Wurst, W., and A. L. Joyner. 1993. Production of targeted embryonic stem cell clones, p. 33–61. In A. L. Joyner (ed.), Gene targeting: a practical approach. IRL Press, Oxford, United Kingdom.
   Google Scholar
• Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725–727.
   PubMed Web of Science ®Google Scholar
• Yagi, T., J. Matsuda, S. Takikita, I. Mohri, and K. Suzuki. 2004. Comparative clinico-pathological study of saposin-A-deficient (SAP-A−/−) and Twitcher mice. J. Neuropathol. Exp. Neurol. 63:721–734.
   PubMedGoogle Scholar
• Zhang, X. L., M. A. Rafi, G. DeGala, and D. A. Wenger. 1991. The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum. Genet. 87:211–215.
   PubMedGoogle Scholar
• Zhao, Q., N. Hay, and C. R. Morales. 1997. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs. Mol. Reprod. Dev. 48:1–8.
   PubMed Web of Science ®Google Scholar